Research and Scholarship Fund
The rate at which people continue to go blind due to glaucoma is still unacceptably high.
This is likely due to late diagnosis and an incomplete understanding of glaucoma, so it is critical that research into this destructive disease continues.
The William A Quinlivan – Glaucoma Australia Research and Scholarship Fund is currently supporting: Identifying genetic causes of primary congenital glaucoma in Australia, a study by Dr Kathryn Burdon & Ms Emmanuelle Souzeau.
In 2015 the Fund is planning to support the TARRGET Study- Targeting At Risk Relatives of Glaucoma patients for Early diagnosis and Treatment.
This study is a direct program targeted at first degree relatives of Australian individuals affected with advanced (“blinding”) open angle glaucoma.
It aims to:
- facilitate their local screening;
- develop a model for the transfer of standardised screening data to a central place to enable standardised diagnosis and feedback of follow-up advice;
- measure the outcomes of the TARRGET program in terms of previously known and new diagnoses of glaucoma suspects, and glaucoma cases.
To help fund Australian glaucoma research, click here to donate to the William A Quinlivan – Glaucoma Australia Research and Scholarship Fund.